caffeine   Click here for help

GtoPdb Ligand ID: 407

Synonyms: Peyona®
Approved drug PDB Ligand
caffeine is an approved drug (FDA (no history prior to 1999), EMA (2009))
Comment: Caffeine is a central nervous system stimulant that causes increased alertness and agitation.
Click here for help
IUPHAR Pharmacology Education Project (PEP) logo

View more information in the IUPHAR Pharmacology Education Project: caffeine

2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 3
Hydrogen bond donors 0
Rotatable bonds 0
Topological polar surface area 61.82
Molecular weight 194.08
XLogP 1.55
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES Cn1cnc2c1c(=O)n(C)c(=O)n2C
Isomeric SMILES Cn1cnc2c1c(=O)n(C)c(=O)n2C
InChI InChI=1S/C8H10N4O2/c1-10-4-9-6-5(10)7(13)12(3)8(14)11(6)2/h4H,1-3H3
InChI Key RYYVLZVUVIJVGH-UHFFFAOYSA-N
Selectivity at GPCRs
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
A2A receptor Primary target of this compound Hs Antagonist Antagonist 4.6 – 5.6 pKi - 1,8,10
pKi 4.6 – 5.6 [1,8,10]
A2B receptor Mm Antagonist Antagonist 4.9 pKi - 4
pKi 4.9 (Ki 1.3x10-5 M) [4]
A3 receptor Primary target of this compound Hs Antagonist Antagonist 4.9 pKi - 8
pKi 4.9 (Ki 1.33x10-5 M) [8]
A2B receptor Primary target of this compound Hs Antagonist Antagonist 4.5 – 5.0 pKi - 2-3,9
pKi 4.5 – 5.0 (Ki 3.38x10-5 – 1.04x10-5 M) [2-3,9]
A1 receptor Primary target of this compound Hs Antagonist Antagonist 4.3 – 5.0 pKi - 1,6,8
pKi 4.3 – 5.0 (Ki 4.49x10-5 – 1.07x10-5 M) [1,6,8]
A2B receptor Rn Antagonist Antagonist 4.5 pKi - 4
pKi 4.5 (Ki 3x10-5 M) [4]
A2A receptor Rn Antagonist Antagonist 4.3 – 4.5 pKi - 5,8,11
pKi 4.3 – 4.5 (Ki 4.8x10-5 – 3.25x10-5 M) [5,8,11]
A1 receptor Rn Antagonist Antagonist 4.4 – 4.4 pKi - 5,7
pKi 4.4 – 4.4 (Ki 4.4x10-5 – 4.1x10-5 M) [5,7]
A3 receptor Rn Antagonist Antagonist <4.0 pKi - 3
pKi <4.0 (Ki >1x10-4 M) [3]
Selectivity at ion channels
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
IP3R1 Hs Antagonist Antagonist - - -
mM range
RyR1 Hs Activator - - - -
pharmacological; mM range
RyR2 Hs Activator - - - -
pharmacological; mM range
RyR3 Hs Activator - - - -
pharmacological; mM range
Ligand mentioned in the following text fields